• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

以及甲状腺肿瘤。

and Thyroid Tumors.

作者信息

Pitsava Georgia, Stratakis Constantine A, Faucz Fabio R

机构信息

Division of Intramural Population Health Research, Eunice Kennedy Shriver National Institutes of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

Section on Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Cancers (Basel). 2021 Jul 30;13(15):3834. doi: 10.3390/cancers13153834.

DOI:10.3390/cancers13153834
PMID:34359735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8345073/
Abstract

Thyroid cancer is the most common type of endocrine malignancy and the incidence is rapidly increasing. Follicular (FTC) and papillary thyroid (PTC) carcinomas comprise the well-differentiated subtype and they are the two most common thyroid carcinomas. Multiple molecular genetic and epigenetic alterations have been identified in various types of thyroid tumors over the years. Point mutations in , as well as and chromosomal rearrangements are common. Thyroid cancer, including both FTC and PTC, has been observed in patients with Carney Complex (CNC), a syndrome that is inherited in an autosomal dominant manner and predisposes to various tumors. CNC is caused by inactivating mutations in the tumor-suppressor gene encoding the cyclic AMP (cAMP)-dependent protein kinase A (PKA) type 1α regulatory subunit () mapped in chromosome 17 (17q22-24). Growth of the thyroid is driven by the TSH/cAMP/PKA signaling pathway and it has been shown in mouse models that PKA activation through genetic ablation of the regulatory subunit can cause FTC. In this review, we provide an overview of the molecular mechanisms contributing to thyroid tumorigenesis associated with inactivation of the gene.

摘要

甲状腺癌是最常见的内分泌恶性肿瘤,其发病率正在迅速上升。滤泡状甲状腺癌(FTC)和乳头状甲状腺癌(PTC)构成了分化良好的亚型,它们是两种最常见的甲状腺癌。多年来,在各种类型的甲状腺肿瘤中已发现多种分子遗传和表观遗传改变。 中的点突变以及 和 染色体重排很常见。在卡尼综合征(CNC)患者中已观察到甲状腺癌,包括FTC和PTC,CNC是一种以常染色体显性方式遗传且易患各种肿瘤的综合征。CNC是由位于17号染色体(17q22 - 24)上的编码环磷酸腺苷(cAMP)依赖性蛋白激酶A(PKA)1α型调节亚基( )的肿瘤抑制基因的失活突变引起的。甲状腺的生长由促甲状腺激素(TSH)/ cAMP / PKA信号通路驱动,并且在小鼠模型中已表明,通过调节亚基 的基因消融激活PKA可导致FTC。在本综述中,我们概述了与 基因失活相关的甲状腺肿瘤发生的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76d/8345073/f90433dc347e/cancers-13-03834-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76d/8345073/f90433dc347e/cancers-13-03834-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f76d/8345073/f90433dc347e/cancers-13-03834-g001.jpg

相似文献

1
and Thyroid Tumors.以及甲状腺肿瘤。
Cancers (Basel). 2021 Jul 30;13(15):3834. doi: 10.3390/cancers13153834.
2
Carney Complex and Its Association With Thyroid Cancer, Molecular Pathway, and Treatment.卡尼综合征及其与甲状腺癌的关联、分子途径和治疗
Cureus. 2023 Nov 8;15(11):e48503. doi: 10.7759/cureus.48503. eCollection 2023 Nov.
3
Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).患有“斑点状皮肤色素沉着、黏液瘤、内分泌功能亢进和神经鞘瘤综合征”(卡尼综合征)的患者中,蛋白激酶A I-α型调节亚基(PRKAR1A)编码基因的突变。
Ann N Y Acad Sci. 2002 Jun;968:3-21. doi: 10.1111/j.1749-6632.2002.tb04323.x.
4
Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.蛋白激酶A的调节亚基I-α(PRKAR1A):一种散发性甲状腺癌的肿瘤抑制基因。
Genes Chromosomes Cancer. 2002 Oct;35(2):182-92. doi: 10.1002/gcc.10112.
5
Thyroid-specific ablation of the Carney complex gene, PRKAR1A, results in hyperthyroidism and follicular thyroid cancer.甲状腺特异性消融 Carney 复合体基因 PRKAR1A 可导致甲状腺功能亢进和滤泡性甲状腺癌。
Endocr Relat Cancer. 2012 May 24;19(3):435-46. doi: 10.1530/ERC-11-0306. Print 2012 Jun.
6
Follicular thyroid cancers demonstrate dual activation of PKA and mTOR as modeled by thyroid-specific deletion of Prkar1a and Pten in mice.滤泡性甲状腺癌表现为 PKA 和 mTOR 的双重激活,这是通过在小鼠中甲状腺特异性缺失 Prkar1a 和 Pten 来模拟的。
J Clin Endocrinol Metab. 2014 May;99(5):E804-12. doi: 10.1210/jc.2013-3101. Epub 2014 Feb 10.
7
Human tumors associated with Carney complex and germline PRKAR1A mutations: a protein kinase A disease!与卡尼综合征及种系PRKAR1A突变相关的人类肿瘤:一种蛋白激酶A疾病!
FEBS Lett. 2003 Jul 3;546(1):59-64. doi: 10.1016/s0014-5793(03)00452-6.
8
Protein kinase A alterations in endocrine tumors.蛋白激酶 A 在内分泌肿瘤中的改变。
Horm Metab Res. 2012 Sep;44(10):741-8. doi: 10.1055/s-0032-1316292. Epub 2012 Jun 29.
9
17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.17q22 - 24染色体缺失以及蛋白激酶A亚基表达和活性改变与促肾上腺皮质激素非依赖性大结节性肾上腺增生的关系
J Clin Endocrinol Metab. 2006 Sep;91(9):3626-32. doi: 10.1210/jc.2005-2608. Epub 2006 Jun 13.
10
Protein kinase A and its role in human neoplasia: the Carney complex paradigm.蛋白激酶A及其在人类肿瘤形成中的作用:卡尼综合征范例
Endocr Relat Cancer. 2004 Jun;11(2):265-80. doi: 10.1677/erc.0.0110265.

引用本文的文献

1
Expression of CLDN1 and EGFR in PTC.CLDN1和EGFR在甲状腺乳头状癌中的表达
Discov Oncol. 2024 Oct 15;15(1):562. doi: 10.1007/s12672-024-01428-9.
2
Possible link between familial susceptibility to cancer and the level of oxidative stress in thyroid cancer patients.甲状腺癌患者家族性癌症易感性与氧化应激水平之间的潜在联系。
Hered Cancer Clin Pract. 2024 Aug 23;22(1):15. doi: 10.1186/s13053-024-00287-3.
3
The common pathogenesis of nodular goiter in both sexes: An exploration into gene expression and signaling pathways.两性结节性甲状腺肿的共同发病机制:对基因表达和信号通路的探索

本文引用的文献

1
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma.仑伐替尼联合帕博利珠单抗是治疗间变性和低分化甲状腺癌的有效治疗选择。
Thyroid. 2021 Jul;31(7):1076-1085. doi: 10.1089/thy.2020.0322. Epub 2021 Apr 15.
2
MANAGEMENT OF ENDOCRINE DISEASE: Carney complex: clinical and genetic update 20 years after the identification of the CNC1 (PRKAR1A) gene.内分泌疾病的管理:卡尼综合征:在识别 CNC1(PRKAR1A)基因 20 年后的临床和遗传更新。
Eur J Endocrinol. 2021 Mar;184(3):R99-R109. doi: 10.1530/EJE-20-1120.
3
PD-1 Blockade in Anaplastic Thyroid Carcinoma.
Heliyon. 2024 Jun 21;10(13):e33411. doi: 10.1016/j.heliyon.2024.e33411. eCollection 2024 Jul 15.
4
Identification of Key Genes and Imbalanced SNAREs Assembly in the Comorbidity of Polycystic Ovary Syndrome and Depression.多囊卵巢综合征与抑郁症共病中关键基因的鉴定及SNAREs组装失衡
Genes (Basel). 2024 Apr 15;15(4):494. doi: 10.3390/genes15040494.
5
Dualistic Effects of PRKAR1A as a Potential Anticancer Target in Cancer Cells and Cancer-Derived Stem Cells.PRKAR1A 的双重作用:作为癌细胞和癌源性干细胞潜在抗癌靶点。
Int J Mol Sci. 2024 Mar 1;25(5):2876. doi: 10.3390/ijms25052876.
6
Analysis of differentially expressed proteins in lymph fluids related to lymphatic metastasis in a breast cancer rabbit model guided by contrast‑enhanced ultrasound.在超声造影引导下的乳腺癌兔模型中,分析与淋巴转移相关的淋巴液中差异表达蛋白
Oncol Lett. 2024 Feb 6;27(4):143. doi: 10.3892/ol.2024.14276. eCollection 2024 Apr.
7
cAMP-PKA/EPAC signaling and cancer: the interplay in tumor microenvironment.cAMP-PKA/EPAC 信号转导与癌症:肿瘤微环境中的相互作用。
J Hematol Oncol. 2024 Jan 17;17(1):5. doi: 10.1186/s13045-024-01524-x.
8
Research progress and application of single-cell sequencing in head and neck malignant tumors.单细胞测序在头颈部恶性肿瘤中的研究进展与应用。
Cancer Gene Ther. 2024 Jan;31(1):18-27. doi: 10.1038/s41417-023-00691-2. Epub 2023 Nov 15.
9
Cancer Predisposition Syndromes and Thyroid Cancer: Keys for a Short Two-Way Street.癌症易感性综合征与甲状腺癌:双向短径的关键因素
Biomedicines. 2023 Jul 29;11(8):2143. doi: 10.3390/biomedicines11082143.
10
The Regulatory Mechanism of miR-574-5p Expression in Cancer.miR-574-5p 在癌症中的表达调控机制。
Biomolecules. 2022 Dec 26;13(1):40. doi: 10.3390/biom13010040.
PD-1 阻断在间变性甲状腺癌中的应用。
J Clin Oncol. 2020 Aug 10;38(23):2620-2627. doi: 10.1200/JCO.19.02727. Epub 2020 May 4.
4
PKA Activates AMPK Through LKB1 Signaling in Follicular Thyroid Cancer.蛋白激酶A通过LKB1信号通路激活甲状腺滤泡癌中的AMPK。
Front Endocrinol (Lausanne). 2019 Nov 8;10:769. doi: 10.3389/fendo.2019.00769. eCollection 2019.
5
Twenty-Five Years Experience on RET Genetic Screening on Hereditary MTC: An Update on The Prevalence of Germline RET Mutations.RET 基因遗传筛查在遗传性 MTC 中的 25 年经验:种系 RET 突变的流行率更新。
Genes (Basel). 2019 Sep 10;10(9):698. doi: 10.3390/genes10090698.
6
Anaplastic thyroid carcinoma: an epidemiologic, histologic, immunohistochemical, and molecular single-institution study.间变性甲状腺癌:一项单机构的流行病学、组织学、免疫组织化学和分子研究。
Hum Pathol. 2018 Dec;82:140-148. doi: 10.1016/j.humpath.2018.07.027. Epub 2018 Aug 1.
7
Deletion of Rap1b, but not Rap1a or Epac1, Reduces Protein Kinase A-Mediated Thyroid Cancer.删除 Rap1b,但不是 Rap1a 或 Epac1,可减少蛋白激酶 A 介导的甲状腺癌。
Thyroid. 2018 Sep;28(9):1153-1161. doi: 10.1089/thy.2017.0528. Epub 2018 Aug 2.
8
The Spectrum of Thyroid Gland Pathology in Carney Complex: The Importance of Follicular Carcinoma.卡尼综合征中甲状腺腺体病变的范围:滤泡癌的重要性。
Am J Surg Pathol. 2018 May;42(5):587-594. doi: 10.1097/PAS.0000000000000975.
9
Effect of Tumor Size on Risk of Metastatic Disease and Survival for Thyroid Cancer: Implications for Biopsy Guidelines.肿瘤大小对甲状腺癌转移疾病风险和生存的影响:对活检指南的启示。
Thyroid. 2018 Mar;28(3):295-300. doi: 10.1089/thy.2017.0526. Epub 2018 Feb 22.
10
Special types of thyroid carcinoma.特殊类型的甲状腺癌。
Histopathology. 2018 Jan;72(1):40-52. doi: 10.1111/his.13348.